Italy: estimated market value of biosimilars 2018-2022, by type

Published by
Juliette Gagliardi,
Dec 19, 2022
This statistic shows the estimated market value of biosimilars in Italy between 2018 and 2022, by type of originator. According to data, the biosimilar produced from Adalimumab is expected to generate a market value of 1,866 million euros between 2018 and 2022, while the market value of Trastuzumab biosimilar is forecasted to reach 1,738 million euros, in the same period.

Estimated market value of biosimilars in Italy between 2018 and 2022, by type of originator*

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

July 2018

Region

Italy

Survey time period

2018

Supplementary notes

*Biopharmaceutical products becoming off-patent between 2017 and 2022.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Generics and biosimilars in Italy "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Generics and biosimilars in Italy

Global overview

6

Generic drugs overview

7

Generics' expenditure

5

Generics' consumption

3

Biosimilar drugs

5

Outlook

5

Further related statistics

17

Further Content: You might find this interesting as well

Statistics

Topics

Generics and biosimilars in ItalyTop pharmaceutical drugsHealth and food supplements market in ItalyNon-prescription drugs in ItalyPharmaceutical market in Italy
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu